Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-061753

Chairman & CEO bought 1,700 shares at an average $18.82 ($31,990)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-13 Purchase : show line 1 in the form +700 $18.10 $12,670 2,958,404 D
2022-05-16 Purchase : show line 2 in the form +1,000 $19.32 $19,320 2,959,404 D
Open-market purchases · 1,700 sh · avg $18.82 · $31,990
Loading xslF345X03/tm2215754-1_4seq1.xml…